Ed is a Certified Public Accountant with significant experience in senior roles in a number of healthcare companies. He is currently Lead Independent Director of First Wave BioPharma Inc. (formerly known as AzurRx BioPharma Inc) and a Trustee of Allegheny College. He has served as the Executive Vice President and Chief Financial Officer of TherapeuticsMD, Aceto Corp, Concordia International, Amerigen Pharmaceuticals, ConvaTec Healthcare, CareFusion Corporation and Mylan and in a variety of finance positions at Pharmacia, American Home Products, Cyanamid and at Arthur Andersen. Most recently, he was Executive Vice President, interim Chief Financial Officer, head of strategy, legal and compliance, and investor and public relations for MiMedx Group Inc, between April 2018 and December 2019. Ed holds a Bachelor of Science in Economics and Political Science from Allegheny College and a Master in Business Administration in Finance and Accounting from Rutgers University.
Ed joined the board of Acacia Pharma in 2018. He is Chairman of the Audit Committee and is also a member of the Remuneration Committee.